AXIM BIOTECHNOLOGIES, INC. (AXIM) Gross profit 2014–2020
AXIM BIOTECHNOLOGIES, INC. (AXIM) annual gross profit history from SEC filings — each fiscal year as reported.
$0FY2020 · since FY2014: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $0 | — |
| FY2019 | $0 | -100.0% |
| FY2018 | $187,103 | +3867.4% |
| FY2017 | $4,716 | +104.4% |
| FY2016 | -$107,071 | -8479.4% |
| FY2015 | -$1,248 | — |
| FY2014 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AXIM financial trends
AXIM RevenueAXIM Net incomeAXIM Net marginAXIM Gross marginAXIM Operating incomeAXIM Operating marginAXIM Operating cash flowAXIM Free cash flowAXIM Capital expendituresAXIM Return on equityAXIM Stock buybacksAXIM Dividends paidAXIM Total assetsAXIM Total liabilitiesAXIM Shareholders’ equityAXIM overview →